Lonza sells capsules and health ingredients unit to Lone Star Funds, retains 40% stake
Lone Star Funds acquires Lonza’s CHI division in a carve-out reshaping pharma capsule supply. Read what this means for the CDMO market.
How Kenox Pharmaceuticals is targeting the OINDP CDMO gap with integrated clinical manufacturing
Kenox Pharmaceuticals announces clinical manufacturing readiness for inhaled and nasal drug products. What this means for OINDP development timelines and IVBE strategy.
Why GSK’s expanded Bora Pharmaceuticals partnership reflects new CDMO selection logic
Explore what the Bora Pharmaceuticals and GSK manufacturing deal reveals about long-term supply strategy and CDMO market shifts. Read the full analysis.
BioSelective Capital’s CDMO acquisition reshapes domestic pharma manufacturing landscape
Forma Life Sciences launches from BioDuro’s CDMO assets. See how this reshoring move changes U.S. oral formulation outsourcing and CDMO competition in 2026.
What Rakuten Medical’s deal with LOTTE Biologics signals for photoimmunotherapy scale-up
Rakuten Medical taps LOTTE Biologics for global supply of its Alluminox cancer platform. Find out what this deal means for photoimmunotherapy’s future.
Why Kashiv BioSciences’ Gujarat plant expansion could redefine biomanufacturing in India
Kashiv BioSciences raises INR 648 crore to expand its Gujarat biologics facility. Find out what this means for India’s role in global drug manufacturing.
What sterile drug manufacturers should expect from AST and Marchesini in 2026
AST, a United States-based provider of aseptic fill-finish systems for pharmaceutical and biotech manufacturers, has entered a strategic partnership with Italy’s Marchesini Group, a global leader in pharmaceutical packaging machinery. Under the agreement announced on December 10, 2025, Marchesini Group has acquired a 44.39 percent equity stake in AST. The deal aims to combine AST’s […]
Can EU-backed CDMO projects redefine pharma supply chains in post-industrial Europe?
The European Commission’s recent approval of €47 million in German state aid for Vetter Pharma’s new aseptic filling facility in Saarlouis marks more than a regional win. It signals a structural shift in how Europe views contract manufacturing organizations, or CDMOs—not merely as outsourcing vendors, but as core pillars of supply chain resilience, regional economic […]
How KVP International’s SafePath-IVD buy could reshape veterinary and human diagnostics
KVP International has announced the acquisition of SafePath Laboratories and IVD Research, a diagnostics manufacturer and contract development and manufacturing organization (CDMO) provider headquartered in Carlsbad, California. With this move, KVP International aims to strengthen its footprint in veterinary diagnostics while unlocking the potential to expand into human health markets. This acquisition provides KVP International […]